No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia

Psychiatric Genetics

Volumn 16, Issue 5, 2006, Pages 221-223

  Philibert, Robert ^a,b   Gunter, Tracy ^a   Hollenbeck, Nancy ^a   Adams, William J ^a   Bohle, Phillip ^a   Packer, Hans ^b   Sandhu, Harinder ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Genetics; Methylenetetrahydrofolate reductase; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL HYPOTHESIS; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SAMPLE; SAMPLE SIZE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ALLELES; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 33748752598     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ypg.0000242192.28526.fa     Document Type: Article

References (14)

1. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M, et al. (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 134:60-66.
2. Fleiss JL (1981). Statistical methods for rates and proportions. New York, New York: Wiley.
3. Guenther BD, Sheppard CA, Tran P, et al. (1999). The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Mol Biol 6:359.
4. Hartl DL, Clark AG (1997). Principles of population genetics. Sunderland, Massachusetts: Sinauer.
5. Leckman JF, Sholomskas D, Thompson WD, et al. (1982). Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39:879-883.
6. Lewis SJ, Zammit S, Gunnell D, et al. (2005). A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet B Neuropsychiatr Genet 135:2-4.
7. Muntjewerff JW, Hoogendoorn ML, Kahn RS, et al. (2005a). Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 135:69-72.
8. Muntjewerff JW, Kahn RS, Blom HJ, et al. (2005b). Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry: Sept 20 [Epub ahead of print].
9. Nurnberger JI Jr, Blehar MC, Kaufmann CA, et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859; discussion 863-864.
10. Philibert RA, Sandhu HK, Hutton AM, et al. (2001). Population-based association analyses of the HOPA12bp polymorphism for schizophrenia and hypothyroidism. Am J Med Genet 105:130-134.
11. Regland B, Johansson BV, Gottfries CG (1994). Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm Gen Sect 98:143-152.
12. Sazci A, Ergul E, Kucukali I, et al. (2005). Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry 29:1113-1123.
13. United States Bureau of the Census; Census 2000.
14. Vilella E, Virgos C, Murphy M, et al. (2005). Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:1169-1174.